2019 Q3 Form 10-K Financial Statement

#000155335019000992 Filed on September 24, 2019

View on sec.gov

Income Statement

Concept 2019 Q3 2019 2018 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $320.2K $1.725M $260.0K
YoY Change -52.91% -26.15% -13.33%
% of Gross Profit
Research & Development $123.3K $237.8K $60.00K
YoY Change -27.34% -79.94% -40.0%
% of Gross Profit
Depreciation & Amortization $347.00 $694.00 $0.00
YoY Change -20.41% -60.21%
% of Gross Profit
Operating Expenses $443.9K $946.2K $320.0K
YoY Change -47.66% -73.14% -21.95%
Operating Profit -$443.9K -$946.2K
YoY Change -47.66% -73.14%
Interest Expense $117.6K $260.3K -$80.00K
YoY Change 27.14% -27.78% -20.0%
% of Operating Profit
Other Income/Expense, Net -$117.6K -$260.3K $0.00
YoY Change 27.14% -151.6%
Pretax Income -$561.5K -$2.659M -$250.0K
YoY Change -40.27% -11.89% -50.0%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$561.5K -$2.659M -$250.0K
YoY Change -40.3% -11.9% -50.0%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$20.42K -$100.1K -$10.00K
COMMON SHARES
Basic Shares Outstanding 27.41M
Diluted Shares Outstanding 27.47M 26.52M

Balance Sheet

Concept 2019 Q3 2019 2018 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.63K $41.34K $20.00K
YoY Change -58.54% 87.82% -71.43%
Cash & Equivalents $74.63K $22.01K
Short-Term Investments
Other Short-Term Assets $12.83K $9.010K $10.00K
YoY Change 28.3% 6.38% 0.0%
Inventory
Prepaid Expenses $11.83K $7.474K
Receivables
Other Receivables $1.000K $1.000K
Total Short-Term Assets $87.46K $50.34K $30.49K
YoY Change -53.58% 65.1% -62.52%
LONG-TERM ASSETS
Property, Plant & Equipment $2.269K $2.620K $1.448K
YoY Change 124.21% 80.69% -54.64%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.269K $2.620K $1.448K
YoY Change 124.21% 80.69% -54.64%
TOTAL ASSETS
Total Short-Term Assets $87.46K $50.34K $30.49K
Total Long-Term Assets $2.269K $2.620K $1.448K
Total Assets $89.73K $52.96K $31.94K
YoY Change -52.63% 65.81% -62.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $790.1K $715.6K $720.0K
YoY Change 23.46% -0.57% -17.24%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $35.00K $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $9.374M $9.303M $9.030M
YoY Change 3.12% 3.04% 2.61%
Total Short-Term Liabilities $11.31M $10.93M $10.20M
YoY Change 9.91% 7.1% -14.18%
LONG-TERM LIABILITIES
Long-Term Debt $3.849M $3.801M $3.530M
YoY Change 8.12% 7.83% 6.33%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $3.849M $3.801M $3.530M
YoY Change 8.12% 7.83% 6.33%
TOTAL LIABILITIES
Total Short-Term Liabilities $11.31M $10.93M $10.20M
Total Long-Term Liabilities $3.849M $3.801M $3.530M
Total Liabilities $15.16M $14.78M $13.73M
YoY Change 9.48% 7.23% -9.71%
SHAREHOLDERS EQUITY
Retained Earnings -$124.9M -$121.7M
YoY Change 1.86% 2.54%
Common Stock $0.00 $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$15.12M -$14.72M -$13.75M
YoY Change
Total Liabilities & Shareholders Equity $89.73K $52.96K $31.94K
YoY Change -52.63% 65.81% -62.22%

Cashflow Statement

Concept 2019 Q3 2019 2018 Q2
OPERATING ACTIVITIES
Net Income -$561.5K -$2.659M -$250.0K
YoY Change -40.3% -11.9% -50.0%
Depreciation, Depletion And Amortization $347.00 $694.00 $0.00
YoY Change -20.41% -60.21%
Cash From Operating Activities -$151.2K -$811.1K -$90.00K
YoY Change -32.42% 73.55% -25.0%
INVESTING ACTIVITIES
Capital Expenditures $2.482K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$2.482K $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 184.5K 832.9K 70.00K
YoY Change -51.21% 100.0% -53.33%
NET CHANGE
Cash From Operating Activities -151.2K -811.1K -90.00K
Cash From Investing Activities -2.482K 0.000
Cash From Financing Activities 184.5K 832.9K 70.00K
Net Change In Cash 33.29K 19.32K -20.00K
YoY Change -78.44% -137.95% -166.67%
FREE CASH FLOW
Cash From Operating Activities -$151.2K -$811.1K -$90.00K
Capital Expenditures $2.482K $0.00
Free Cash Flow -$813.6K -$90.00K
YoY Change 74.08% -25.0%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
296852
CY2019 bnet Adjustment To Additional Paid In Capital Modification Of Warrants
AdjustmentToAdditionalPaidInCapitalModificationOfWarrants
188493
CY2018 bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
349656
CY2019 bnet Adjustment To Additional Paid In Capital Modification Ofoptions
AdjustmentToAdditionalPaidInCapitalModificationOfoptions
222300
CY2018 bnet Adjustments To Additional Paid In Capital Related Party Debt Extinguishment
AdjustmentsToAdditionalPaidInCapitalRelatedPartyDebtExtinguishment
1685252
CY2019 bnet Common Stock Conversions Inducements
CommonStockConversionsInducements
CY2018 bnet Common Stock Conversions Inducements
CommonStockConversionsInducements
10784
CY2019 bnet Common Stock Voting Rights Votes Per Share
CommonStockVotingRightsVotesPerShare
1
CY2019Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
173245
CY2018Q2 bnet Computers And Office Equipment Gross
ComputersAndOfficeEquipmentGross
171613
CY2019 bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
100000
CY2018 bnet Conversion Of Debt And Liabilities
ConversionOfDebtAndLiabilities
213718
CY2019 bnet Conversion Of Deferred Compensation Into Note Payable Affiliate
ConversionOfDeferredCompensationIntoNotePayableAffiliate
150000
CY2018 bnet Conversion Of Deferred Compensation Into Note Payable Affiliate
ConversionOfDeferredCompensationIntoNotePayableAffiliate
CY2019 bnet Deferred Compensation Consecutive Trading Days
DeferredCompensationConsecutiveTradingDays
P10D
CY2019 bnet Deferred Compensation Conversion Days
DeferredCompensationConversionDays
P5D
CY2019 bnet Deferred Compensation Forgiven Related Parties
DeferredCompensationForgivenRelatedParties
CY2018 bnet Deferred Compensation Forgiven Related Parties
DeferredCompensationForgivenRelatedParties
1685252
CY2018 bnet Deferred Compensation Liability Amount Cancelled
DeferredCompensationLiabilityAmountCancelled
2404000
CY2019 bnet Defined Contribution Pension And Other Postretirement Plans Minimum Age
DefinedContributionPensionAndOtherPostretirementPlansMinimumAge
P21Y
CY2019 bnet Effective Income Tax Rate Reconciliation Deferred Compensation Amount
EffectiveIncomeTaxRateReconciliationDeferredCompensationAmount
CY2018 bnet Effective Income Tax Rate Reconciliation Deferred Compensation Amount
EffectiveIncomeTaxRateReconciliationDeferredCompensationAmount
790000
CY2019 bnet Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount
EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount
850000
CY2018 bnet Effective Income Tax Rate Reconciliation Expiration Of Net Operating Allowance Amount
EffectiveIncomeTaxRateReconciliationExpirationOfNetOperatingAllowanceAmount
1201000
CY2013Q2 bnet Extension Of Exercise Period Annual Payment Per Option Or Warrant
ExtensionOfExercisePeriodAnnualPaymentPerOptionOrWarrant
0.05
CY2019 bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
CY2018 bnet Gain Loss On Extinguishment Of Liabilities
GainLossOnExtinguishmentOfLiabilities
875852
CY2019 bnet Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
2000
CY2018 bnet Income Tax Reconciliation Permanent Differences
IncomeTaxReconciliationPermanentDifferences
3000
CY2019 bnet Interest Expense Related To The Modification Of Warrants
InterestExpenseRelatedToTheModificationOfWarrants
25467
CY2019 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2019 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2019 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2019 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2019 dei Trading Symbol
TradingSymbol
bnet
CY2019 dei Entity Central Index Key
EntityCentralIndexKey
0000875729
CY2019 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2019 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019 dei Entity Registrant Name
EntityRegistrantName
BION ENVIRONMENTAL TECHNOLOGIES INC
CY2019 dei Entity Small Business
EntitySmallBusiness
true
CY2019 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
6250
CY2019Q2 us-gaap Assets
Assets
52956
CY2019 dei Amendment Flag
AmendmentFlag
false
CY2019 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2019 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019 dei Document Period End Date
DocumentPeriodEndDate
2019-06-30
CY2019 dei Document Type
DocumentType
10-K
CY2019Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
27411379
CY2018Q4 dei Entity Public Float
EntityPublicFloat
10500000
CY2019 dei Entity Shell Company
EntityShellCompany
false
CY2019 dei Security12g Title
Security12gTitle
Common Stock
CY2019Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
715554
CY2018Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
719633
CY2019Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794769
CY2018Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2794305
CY2019Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
110126802
CY2018Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
108117330
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1391671
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
236100
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
63880
CY2018 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
48350
CY2019Q2 bnet Interest Rate On Deferred Compensation
InterestRateOnDeferredCompensation
0.04
CY2019Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9303270
CY2018Q2 bnet Loans Payable Current Including Accrued Interest And Late Charges
LoansPayableCurrentIncludingAccruedInterestAndLateCharges
9028983
CY2019 bnet Modification Of Warrants
ModificationOfWarrants
163026
CY2019 bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
896801
CY2018 bnet Proceeds From The Sale Of Units
ProceedsFromTheSaleOfUnits
350496
CY2018 bnet Sale Of Units Value
SaleOfUnitsValue
350496
CY2019 bnet Sale Of Units Value
SaleOfUnitsValue
896801
CY2018Q2 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2017Q2 bnet Shares Held By Subsidiaries
SharesHeldBySubsidiaries
704309
CY2019 bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
514
CY2018 bnet Shares Issued For Warrant Exercise Commissions
SharesIssuedForWarrantExerciseCommissions
CY2019 bnet Stock Issued During Period Shares Commissions On Sale Of Units
StockIssuedDuringPeriodSharesCommissionsOnSaleOfUnits
1028
CY2018 bnet Stock Issued During Period Value Commissions On Sale Of Units
StockIssuedDuringPeriodValueCommissionsOnSaleOfUnits
14875
CY2018 bnet Warrants Exercised For Common Stock
WarrantsExercisedForCommonStock
78625
CY2019 bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
4850
CY2018 bnet Warrants Issued For Unit Commissions
WarrantsIssuedForUnitCommissions
CY2019 bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
330000
CY2018 bnet Warrants Subscribed But Unissued Subscriptions Receivable
WarrantsSubscribedButUnissuedSubscriptionsReceivable
134650
CY2019 bnet Weighted Average Exercise Price For Outstanding Warrants
WeightedAverageExercisePriceForOutstandingWarrants
0.95
CY2019 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
1286743
CY2018 bnet Weighted Average Number Of Shares Issued During Period
WeightedAverageNumberOfSharesIssuedDuringPeriod
395155
CY2019 bnet Weighted Average Remaining Contractual Life For Outstanding Warrants
WeightedAverageRemainingContractualLifeForOutstandingWarrants
P3Y219D
CY2019Q2 bnet Working Capital
WorkingCapital
-10876000
CY2019Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3801168
CY2018Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
3525216
CY2019Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
874162
CY2018Q2 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
421641
CY2019Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18655000
CY2018Q2 us-gaap Assets
Assets
31935
CY2019Q2 us-gaap Assets Current
AssetsCurrent
50340
CY2018Q2 us-gaap Assets Current
AssetsCurrent
30487
CY2019Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2018Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
401470
CY2018Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
22013
CY2017Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
72932
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41335
CY2019 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19322
CY2018 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-50919
CY2019Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
16700000
CY2019Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2018Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
CY2019Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
504650
CY2018Q2 us-gaap Common Stock Share Subscribed But Unissued Subscriptions Receivable
CommonStockShareSubscribedButUnissuedSubscriptionsReceivable
174650
CY2019Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2018Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2019Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28068688
CY2018Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25939892
CY2017Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24748213
CY2019Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27364379
CY2018Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25235583
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24043904
CY2019Q2 us-gaap Common Stock Value
CommonStockValue
CY2018Q2 us-gaap Common Stock Value
CommonStockValue
CY2019 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Concentrations of credit risk:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's financial instruments that are exposed to concentrations of credit risk consist of cash. The Company's cash is in demand deposit accounts placed with federally insured financial institutions and selected brokerage accounts. Such deposit accounts at times <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may </div>exceed federally insured limits. The Company has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">not</div> experienced any losses on such accounts.</div></div></div></div>
CY2009Q1 us-gaap Construction Loan
ConstructionLoan
7750000
CY2018Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18853000
CY2018Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18853000
CY2019 us-gaap Depreciation
Depreciation
1314
CY2018 us-gaap Depreciation
Depreciation
1744
CY2019Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2018Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
CY2019Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
11864000
CY2018Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
12394000
CY2019Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1340000
CY2018Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1340000
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
1027000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
875000
CY2019Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4424000
CY2018Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4244000
CY2019Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18655000
CY2019 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
CY2018 us-gaap Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation
DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.10
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.12
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1
CY2019Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
0
CY2019 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1724677
CY2018 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2335499
CY2019 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-4930
CY2018 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2994
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-198000
CY2018 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-584000
CY2019 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
CY2018 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-275000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-557000
CY2018 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1025000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-97000
CY2018 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-110000
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8858
CY2018 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
76604
CY2019 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
668600
CY2018 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
813600
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
531
CY2018 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1048
CY2019 us-gaap Interest Expense
InterestExpense
413057
CY2018 us-gaap Interest Expense
InterestExpense
360492
CY2019 us-gaap Interest Paid Net
InterestPaidNet
CY2018 us-gaap Interest Paid Net
InterestPaidNet
CY2019Q2 us-gaap Liabilities
Liabilities
14727554
CY2018Q2 us-gaap Liabilities
Liabilities
13726873
CY2019Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52956
CY2018Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
31935
CY2019Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10926386
CY2018Q2 us-gaap Liabilities Current
LiabilitiesCurrent
10201657
CY2019Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2018Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2222670
CY2019Q2 us-gaap Minority Interest
MinorityInterest
49408
CY2018Q2 us-gaap Minority Interest
MinorityInterest
54338
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
832921
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
416462
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2482
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-811117
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-467381
CY2019 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2654202
CY2018 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3014990
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-413057
CY2018 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
504576
CY2019 us-gaap Operating Expenses
OperatingExpenses
2246075
CY2018 us-gaap Operating Expenses
OperatingExpenses
3522560
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-2246075
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
-3522560
CY2019Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
50914000
CY2019 us-gaap Other Noncash Expense
OtherNoncashExpense
448690
CY2018 us-gaap Other Noncash Expense
OtherNoncashExpense
395659
CY2019Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2018Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
1000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
63880
CY2018 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
14875
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2482
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2019Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
8005
CY2018Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
7474
CY2019 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
897000
CY2018 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
418000
CY2019 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
CY2018 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30500
CY2019 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
CY2018 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
67841
CY2019 us-gaap Profit Loss
ProfitLoss
-2659132
CY2018 us-gaap Profit Loss
ProfitLoss
-3017984
CY2019Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2797385
CY2018Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2795753
CY2019Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2616
CY2018Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1448
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
17500
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
520084
CY2018 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1185317
CY2019Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-124346158
CY2018Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121691956
CY2019 us-gaap Revenues
Revenues
CY2018 us-gaap Revenues
Revenues
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
2647500
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
655000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.36
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
176575
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
721084
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2129112
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
7411600
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.08
CY2018 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
365312
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
70625
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
20375
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4545097
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
6827225
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
7411600
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.42
CY2018Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.11
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.08
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
2.35
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
1.26
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.76
CY2019 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.74
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
20375
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y36D
CY2018Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
CY2019Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2017 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y328D
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y292D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y36D
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
236100
CY2018 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1376250
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
655000
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.36
CY2019Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
33400
CY2018Q2 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Current
SharesSubjectToMandatoryRedemptionSettlementTermsAmountCurrent
31400
CY2018 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2018 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
213718
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
100000
CY2018 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42583
CY2019 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
93408
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-14724006
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-13749276
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-15119282
CY2018Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-13694938
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-14674598
CY2019Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2018 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2019 us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-weight: bold;">Use of estimates:</div></div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In preparing the Company&#x2019;s consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div>
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26522326
CY2018 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24439059
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
26522326
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
24439059

Files In Submission

Name View Source Status
0001553350-19-000992-index-headers.html Edgar Link pending
0001553350-19-000992-index.html Edgar Link pending
0001553350-19-000992.txt Edgar Link pending
0001553350-19-000992-xbrl.zip Edgar Link pending
bion_10k.htm Edgar Link pending
bion_ex10z100.htm Edgar Link pending
bion_ex10z101.htm Edgar Link pending
bion_ex10z102.htm Edgar Link pending
bion_ex31z1.htm Edgar Link pending
bion_ex31z2.htm Edgar Link pending
bion_ex32z1.htm Edgar Link pending
bion_ex32z2.htm Edgar Link pending
bnet-20190630.xml Edgar Link completed
bnet-20190630.xsd Edgar Link pending
bnet-20190630_cal.xml Edgar Link unprocessable
bnet-20190630_def.xml Edgar Link unprocessable
bnet-20190630_lab.xml Edgar Link unprocessable
bnet-20190630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending